about
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseCommon variants at five new loci associated with early-onset inflammatory bowel diseaseGenome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociComparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effectsDiverse genome-wide association studies associate the IL12/IL23 pathway with Crohn DiseaseMeta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Genetic predictors of medically refractory ulcerative colitisFucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseGastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale SurveyWhat is the role of serological markers in IBD? Pediatric and adult data.Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patientsAntibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel DiseaseA common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaDissecting Allele Architecture of Early Onset IBD Using High-Density GenotypingSurgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's diseaseDiagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.Crohn's jejunoileitis: the pediatrician's perspective on diagnosis and management.Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitisInherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.Special issues in pediatric inflammatory bowel disease.The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis.Management of the pregnant IBD patient.Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.Update in pediatric inflammatory bowel diseaseAge of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis.Multiple primary cutaneous plasmacytomas: an unusual presentation.Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients.Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's DiseaseConsensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Have we changed the natural history of pediatric Crohn's disease with biologics?Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.Real World Experience With Natalizumab at a Tertiary Care Pediatric IBD Center.Therapeutic drug monitoring in inflammatory bowel disease.Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult Population.
P50
Q22251082-2686FADA-1E6D-4536-BC01-20E445C3F732Q24600801-925BAF87-E62F-429F-BF25-D43908438407Q24618592-000EB8A1-22B8-40C4-B18D-094F45BC42B1Q24631241-1112915A-53A8-424B-9E60-1CCD241260E3Q24644398-4BDA3E4C-1D26-4CE7-8345-930EEF277801Q28943305-B73F823C-99E1-428A-B53A-6507D9BCCEE7Q28943368-198B6483-06ED-440D-ABFF-E918AA95130CQ29417151-BB5A5310-B19E-430E-BFE7-B9FE11434E44Q30489693-D0E8016B-0DA4-45C8-9672-0BE3A669843DQ33507220-E985DE27-82AC-4402-BB97-3DDAE0572F7BQ33715448-4BAE5324-B6EE-4688-8CCE-8B41C44BB315Q34057490-3D3FC405-92BF-4364-801C-897F766B6864Q34433052-950D8AC3-BF4E-4B99-80E5-17A7D790F5ABQ35670321-320D389D-FCEE-46B7-853E-3E61B828A327Q35687929-AC490F19-380B-4C1F-97C3-0DD1A4F2AAE5Q35748693-C9B8EA01-00C1-4C37-B22C-518E54D3DBACQ36095561-82702B6A-9240-4F22-AE38-C863AC31EF88Q36171739-97ACFFC2-FFA1-47FB-9C93-477C25C5E5F5Q36204582-DC0EFBF2-3DC8-49A7-88C6-FD2FBA91466FQ36468290-B169EF3F-2E42-4D59-ACE8-541C472C2F2CQ36742866-1863EE62-723D-4335-B105-817DB4029429Q37058876-92F16D79-5376-455F-9152-CEC490C17ACEQ37197292-510AFC38-B1E5-46D8-A9D4-7AA585E44FC8Q37213026-BC73E0E6-A688-4C5B-A76A-CBC8AA8DE6FEQ37216502-98557C23-025E-4154-97BD-17920F81A0C6Q37245232-2726ED7E-4EA4-4556-900F-F0B7BD7F66ABQ37279540-1C5C3302-CCA4-49E9-BB77-71BE9032CF0FQ37305418-3535F7D6-EE88-4BA1-A0A4-CE36E9C212BDQ37343263-34C40449-31AE-432B-A68E-925E4CAC2598Q37385056-F67733EE-0D60-4DF9-8A57-F32C61EED268Q37554366-B71BC660-8E77-418B-BAE9-61E637D674B4Q37570917-7B297F8F-313C-4484-AD01-E54744B2B0BCQ37594836-2EB3D97C-A303-4A30-814F-BF838BC941E8Q37656048-4BDA69B3-EEB7-4312-8F1F-F41D3E70B4A3Q37827687-45405AAA-B63E-4607-92BF-0C7613D650C1Q38223555-BCAC87E6-A921-4D81-92F9-40F12166E3D1Q38627135-BD19F8A8-AC51-40FF-91CD-D837F5FFE8D0Q38841591-034E9BB4-39AE-4AF1-BA02-896D45118299Q38943484-4617ADCC-AB6B-4786-93BA-5DFB3C8A6503Q40027827-318D39F5-00B8-48E3-8B82-2D8B177AF4A7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Marla Dubinsky
@ast
Marla Dubinsky
@en
Marla Dubinsky
@es
Marla Dubinsky
@nl
Marla Dubinsky
@sl
type
label
Marla Dubinsky
@ast
Marla Dubinsky
@en
Marla Dubinsky
@es
Marla Dubinsky
@nl
Marla Dubinsky
@sl
prefLabel
Marla Dubinsky
@ast
Marla Dubinsky
@en
Marla Dubinsky
@es
Marla Dubinsky
@nl
Marla Dubinsky
@sl
P214
P244
P106
P21
P213
0000 0003 8284 9894
P214
P244
P31
P735
P7859
lccn-n00074270